BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11860405)

  • 1. Effects of 5-HT(3) antagonism on postprandial gastric volume and symptoms in humans.
    Kuo B; Camilleri M; Burton D; Viramontes B; McKinzie S; Thomforde G; O'Connor MK; Brinkmann BH
    Aliment Pharmacol Ther; 2002 Feb; 16(2):225-33. PubMed ID: 11860405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a proton pump inhibitor on postprandial gastric volume, emptying and symptoms in healthy human subjects: a pilot study.
    Grudell AB; Camilleri M; Burton DD; Stephens DA
    Aliment Pharmacol Ther; 2006 Oct; 24(7):1037-43. PubMed ID: 16984497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of NK1 receptors on gastric motor functions and satiation in healthy humans: results from a controlled trial with the NK1 antagonist aprepitant.
    Jacob D; Busciglio I; Burton D; Halawi H; Oduyebo I; Rhoten D; Ryks M; Harmsen WS; Camilleri M
    Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G505-G510. PubMed ID: 28814387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of oral CCK-1 agonist GI181771X on fasting and postprandial gastric functions in healthy volunteers.
    Castillo EJ; Delgado-Aros S; Camilleri M; Burton D; Stephens D; O'Connor-Semmes R; Walker A; Shachoy-Clark A; Zinsmeister AR
    Am J Physiol Gastrointest Liver Physiol; 2004 Aug; 287(2):G363-9. PubMed ID: 15246968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of somatostatin analog on postprandial satiation in obesity.
    Cremonini F; Camilleri M; Gonenne J; Stephens D; Oenning L; Baxter K; Foxx-Orenstein A; Burton D
    Obes Res; 2005 Sep; 13(9):1572-9. PubMed ID: 16222060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of GLP-1 on gastric volume, emptying, maximum volume ingested, and postprandial symptoms in humans.
    Delgado-Aros S; Kim DY; Burton DD; Thomforde GM; Stephens D; Brinkmann BH; Vella A; Camilleri M
    Am J Physiol Gastrointest Liver Physiol; 2002 Mar; 282(3):G424-31. PubMed ID: 11841992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind, randomized, placebo-controlled dose-ranging study to evaluate the efficacy of alosetron in the treatment of irritable bowel syndrome.
    Bardhan KD; Bodemar G; Geldof H; Schütz E; Heath A; Mills JG; Jacques LA
    Aliment Pharmacol Ther; 2000 Jan; 14(1):23-34. PubMed ID: 10632642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind, randomized, placebo-controlled study to evaluate the effects of tegaserod on gastric motor, sensory and myoelectric function in healthy volunteers.
    Talley NJ; Camilleri M; Burton D; Thomforde G; Koch K; Rucker MJ; Peterson J; Zinsmeister AR; Earnest DL
    Aliment Pharmacol Ther; 2006 Sep; 24(5):859-67. PubMed ID: 16918891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of gastric volume or emptying on meal-related symptoms after liquid nutrients in obesity: a pharmacologic study.
    Delgado-Aros S; Camilleri M; Castillo EJ; Cremonini F; Stephens D; Ferber I; Baxter K; Burton D; Zinsmeister AR
    Clin Gastroenterol Hepatol; 2005 Oct; 3(10):997-1006. PubMed ID: 16234046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of amitriptyline on gastric sensorimotor function and postprandial symptoms in healthy individuals: a randomized, double-blind, placebo-controlled trial.
    Bouras EP; Talley NJ; Camilleri M; Burton DD; Heckman MG; Crook JE; Richelson E
    Am J Gastroenterol; 2008 Aug; 103(8):2043-50. PubMed ID: 18803000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipase Supplementation before a High-Fat Meal Reduces Perceptions of Fullness in Healthy Subjects.
    Levine ME; Koch SY; Koch KL
    Gut Liver; 2015 Jul; 9(4):464-9. PubMed ID: 25287168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of gastric emptying or accommodation with satiation, satiety, and postprandial symptoms in health.
    Halawi H; Camilleri M; Acosta A; Vazquez-Roque M; Oduyebo I; Burton D; Busciglio I; Zinsmeister AR
    Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G442-G447. PubMed ID: 28774870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of asimadoline, a kappa-opioid agonist, on satiation and postprandial symptoms in health.
    Delgado-Aros S; Chial HJ; Cremonini F; Ferber I; McKinzie S; Burton DD; Camilleri M
    Aliment Pharmacol Ther; 2003 Sep; 18(5):507-14. PubMed ID: 12950423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In functional dyspepsia, hypersensitivity to postprandial distention correlates with meal-related symptom severity.
    Farré R; Vanheel H; Vanuytsel T; Masaoka T; Törnblom H; Simrén M; Van Oudenhove L; Tack JF
    Gastroenterology; 2013 Sep; 145(3):566-73. PubMed ID: 23702005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of exenatide and erythromycin on postprandial symptoms and their relation to gastric functions.
    Yoon SB; Choi MG; Lim CH; Kim JS; Cho YK; Park JM; Lee IS; Kim SW; Choi KY; Chung IS
    Digestion; 2012; 85(3):211-8. PubMed ID: 22354133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Independent influences of body mass and gastric volumes on satiation in humans.
    Delgado-Aros S; Cremonini F; Castillo JE; Chial HJ; Burton DD; Ferber I; Camilleri M
    Gastroenterology; 2004 Feb; 126(2):432-40. PubMed ID: 14762780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the 5-HT3 receptor antagonist, ondansetron, on gastric size in dyspeptic patients with impaired gastric accommodation.
    Marzio L; Cappello G; Grossi L; Manzoli L
    Dig Liver Dis; 2008 Mar; 40(3):188-93. PubMed ID: 18242155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of nutrients and serotonin 5-HT3 antagonism on symptoms evoked by distal gastric distension in humans.
    Ladabaum U; Brown MB; Pan W; Owyang C; Hasler WL
    Am J Physiol Gastrointest Liver Physiol; 2001 Feb; 280(2):G201-8. PubMed ID: 11208541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive measurement of gastric accommodation in patients with idiopathic nonulcer dyspepsia.
    Kim DY; Delgado-Aros S; Camilleri M; Samsom M; Murray JA; O'Connor MK; Brinkmann BH; Stephens DA; Lighvani SS; Burton DD
    Am J Gastroenterol; 2001 Nov; 96(11):3099-105. PubMed ID: 11721755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of alosetron on gastrointestinal transit time and rectal sensation in patients with irritable bowel syndrome.
    Thumshirn M; Coulie B; Camilleri M; Zinsmeister AR; Burton DD; Van Dyke C
    Aliment Pharmacol Ther; 2000 Jul; 14(7):869-78. PubMed ID: 10886042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.